Search

everythinglearnresearchcommunity

for

Search:↓

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

EGFR helps mouse hair follicles stop growing by reducing certain growth regulators.

Homeopathic treatment improved thyroid function and well-being in a woman with hypothyroidism.

Hair loss from telogen effluvium happens when a disturbance or imbalance causes hair to fall out prematurely.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

Testosterone helps human pancreatic cells increase insulin release.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Postmenopausal women with unusual hair growth should be checked for ovarian tumors.

Trichotillometry is a reliable method to measure hair strength and assess hair loss treatments.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Trichotillomania was successfully treated with risperidone and naltrexone.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

A woman had temporary hair loss after a facelift, which improved on its own within a year.

Alopecia areata patients are more likely to have thyroid disorders than healthy individuals.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Skin and hair cells release serotonin and histamine naturally, which could help improve skin health.

Activating TRPA1 reduces scarring and promotes tissue regeneration.

Tigason improved hair growth in a boy with monilethrix without side effects.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.